FDA EUA has been submitted for SARS-CoV-2 kit, awaiting final clearance Clinical trials initiated for the FDA submission for the Enteric Protozoan kit Can now sell to select customers in the US under a Section IVc exemption1 until FDA EUA is received - from the last investor presentation - I believe the end of November for the final clearance - hopefully - but short answer to your question - I am not sure
GSS Price at posting:
$1.33 Sentiment: Hold Disclosure: Held
